
The sessions of the First Itinerant Congress of Ophthalmology will conclude in Holguín, on May 17, after its development throughout the country since March, under the auspices of the Cuban Society of this medical specialty and the Ramón Pando Ferrer Cuban Institute of Ophthalmology.
Read more In Holguín, First Traveling Congress of Ophthalmology
Photo: Cubadebate
The first clinical studies of the application of Cuba’s first nasal vaccine candidate, named Mambisa, to patients convalescing from Covid-19 and as a booster are ongoing.
Industrial production has begun of Cuba’s candidate vaccines Soberana 02 and Abdala (CIGB-66), two of the four developed on the island to combat COVID-19, with progress advancing at BioCubaFarma facilities.
Page 328 of 496